The study of the autologous immune response to cancer avoids the difficulties encountered in the use of xenoantisera and may identify antigens of physiological relevance. However, the low titer and incidence of autologous antibody to melanoma have hampered further evaluation. By utilizing acid dissociation and ultrafiltration of serum, we have been able to augment the detectable autologous immune response to melanoma in the majority of patients studied. In autologous system Y-Mel 84:420, serum S150 demonstrated a rise in titer from 1:32 in native sera to 1:262,044 after dissociation. The antigen detected by S150 was found to be broadly represented on melanoma, glioma, renal cell carcinoma, neuroblastoma, and head and neck carcinoma cell lines. It did not react with bladder or colon carcinoma, fetal fibroblasts, pooled platelets, lymphocytes and red blood cells, or autologous cultured lymphocytes. Using polyacrylamide gel electrophoresis, S150 detects a 66,000-mol wt antigen in spent tissue culture media and serum ultrafiltrate. In cell lysate two bands between 20,000 and 30,000 mol wt are detected by S150. The 66,000-mol wt antigen is sensitive to trypsin digestion and but is resistant to pepsin and heat inactivation. Exposure of spent media to trypsin results in the development of a 24,000-mol wt band that appears to correspond to the antigen detected in the cell lysate. The difference between the antigens detected in the cell lysate as compared with spent media and serum ultrafiltrate may be due to degradation during cell lysis. We conclude that melanoma-associated antigens are present in the serum of patients with melanoma and are shed or secreted by their tumor cells.
Introduction
Numerous investigators have utilized a variety of antibody probes in the hopes of characterizing antigens that may distinguish melanoma and other tumors from their normal counterparts. The antibodies employed have been derived from polyclonal xenogeneic and allogeneic antisera (1-7) as well as murine and human monoclonal antibodies (8) (9) (10) (11) (12) (13) (14) . Although these heterologous antibodies have been found to detect tumor-associated antigens, when sufficiently studied they have also been noted to react with normal cell constituents (15) . Our investigations have focused upon the humeral immune response produced by the host. The advantage of studying autologous antibody reactivity is that it may detect antigens not apparent to heteroantisera. In addition, because the antibodies are produced by the host, they are directed against physiologically relevant antigens that may provide a better understanding of the role of the host-tumor interaction.
Antibody against autologous tumor cell surface antigens was first reported by Carey et al. (16, 17) and Shiku et al. (18, 19) using sensitive microserologic assays and cultured tumor cells. Antigens described in those studies were divided into three classes: those that are restricted to the tumor of a single individual (class I); those that are shared among tumors of a similar histotype or ontogeny and rarely, if ever, found in nonneoplastic cells (class II); and those that are found in nonneoplastic cells as well as tumors (class III). These authors showed antibody against autologous antigens in a third of melanoma patients studied-a finding confirmed in our investigations (20) . However, the low incidence and weak titer of autologous antibody to melanoma have hampered continued investigation and has raised questions regarding the relevance of humeral immunity in melanoma.
We postulated that our failure to detect autologous antibody to melanoma with greater frequency may be due to the presence of circulating antigen forming immune complexes. To pursue this we modified a technique reported by Sjorgen et al. (21) to dissociate antibody from antigen in the sera of patients with melanoma. We have previously reported that this technique is successful in enhancing autologous antibody reactivity in 9 of 10 cases studied (20, 22) . Serial studies of autologous antibody reactivity, in native and dissociated sera, have demonstrated correlations between clinical course and disease progression (22) . In addition, we have found that the presence host-derived antibody reactivity against an allogeneic melanoma cell line is a predictor of eventual disease recurrence (23) .
At present, the analysis of antigens detected by autologous antibody depends primarily upon determination of specificity in tests against a variety of malignant and nonmalignant cell lines. A more definitive approach is to characterize the antigen by immunochemical means. To date this has been difficult because of the low titer of antibody detectable in native sera and insufficient quantity of antigen. Only two successful immunochemical characterizations of class I melanoma antigens have been reported. Carey et al. (17) partially characterized a 25,000-40,000-mol wt class I antigen (AU) by gel filtration chromatography. More recently, Real et al. (24) reported a class I glycoprotein of 90,000 mol wt isolated by immunoprecpitation with autologous antibody and radiolabeled melanoma cells.
Our ability to enhance autologous antibody titer by dissociation of immune complexes has allowed immunochemical analysis to proceed. We report the successful use of polyacrylamide gel electrophoresis (PAGE) with polyclonal autologous antibody in the detection of a class II melanoma antigen isolated from cell lysate, serum, and spent media.
Methods

Cell lines
Melanoma cells. Sterile tumor specimens were obtained, established, and maintained in a manner reported previously (20, 22 Acid dissociation and ultrafiltration (AD& U)' The method, initially described by Sjogren et al. (21) , was used to dissociate immune complexes. Briefly, a 60-ml ultrafiltration chamber and Amicon HP-30 membrane (Amicon Corp., Danvers, MA) were used. 2-3 ml of prefiltered (0.45 ,um, Millipore Corp., Bedford, MA) serum was added to 50 ml of glycine-saline buffer, 0.1 M, pH 3.1, in the ultrafiltration chamber. Ultrafiltration was performed at 4°C under 10 psi N2 until the original volume of the test solution was reached. This process was repeated twice and then the serum was washed three times with 50 ml ofPBS, and concentrated to the original volume of serum. The total time involved varied from 24 to 48 h depending on the serum used.
Absorption analysis
Absorptions were performed using a wide range of fresh, cryopreserved, and cultured heterologous, allogeneic, and autologous cells (see Table I ). These were washed three times and mixed at a 1:1 vol/vol (1 X 108 cells/ml minimum) with the serum to be tested (0.1 ml, at a serum dilution two doublings above the endpoint of the titration for that serum). Absorptions were carried out for 30 min at 4°C and then 30 min at 37°C. Specimens were then centrifuged at 2,000 rpm for 20 min in a Sorvall RC3B refrigerated centrifuge (DuPont-Sorvall, New- town, CT). Supernatant serum was retested, with an aliquot of control unabsorbed serum incubated in parallel, using protein A to assess the degree of specificity antibody absorption.
Isolation ofmelanoma antigens
Solubilization of melanoma cells. Preparation of melanoma antigens followed the method reported by Lloyd et al. (26) . Briefly, cells from a confluent 150-cm2 flask (107 cells) were detached with EDTA and washed twice using PBS. 1.5 ml of lysate buffer (0.15 M NaCl, 0.01 M Tris, 0.01 M Mg C12, 1 mM phenylmethysulfonyl fluoride, 2 U/ml aprotinin, 0.5% NP-40, pH 7.2) was added to each 0.1 ml of pellet. After incubating 15 min at 20'C, the cells were spun at 100,000 g for 30 min. The solution was clarified through a 0.22-jum filter, aliquotted, and stored at -70'C.
Isolation ofthe ultrafiltratefrom serum. The ultrafiltrate, obtained by acid dissociation and ultrafiltration, was concentrated by lyophilization. Preliminary work (22) and the absorption analysis illustrated in Fig. 1 gous melanoma cell line Y-Mel 84:420. After AD&U, enhanced reactivity to 1:262,044 was noted, the highest titer yet reported in any autologous system (Fig. 1) . As can be seen, enhanced autologous antibody reactivity could be ablated by the addition of autologous ultrafiltrate, native serum, and spent tumor culture medium. We have previously reported that sera from 10 normal individuals showed no reactivity against melanoma cells before or after AD&U (20) . Specificity analysis of serum S150. Reactivity of serum S150 was tested by direct and absorption analysis against a variety of normal and malignant cell lines. The results are summarized in Table I Serial autologous studies ofsystem Y-Mel 84:420. Sera obtained at 1-4-mo intervals were tested before and after AD&U against autologous melanoma cells by protein A hemadsorption. The results were then correlated with clinical status and are illustrated in Fig. 2 . In sera subjected to AD&U (POST), antibody titer demonstrated a progressive rise that paralleled recurrence and progressive disease. The etiology of the first two drops is not clear but may be the result of treatment with surgery and radiotherapy, respectively. The third drop in antibody titer may be due to treatment with interferon as has been reported previously (22) . Of additional note is the preterminal rise in both native (PRE) and AD&U (POST) antibody titers. Serum obtained at month 48 was used for subsequent immunochemical analysis.
Immunochemical analysis. Cell lysate, spent media, and serum ultrafiltrate underwent PAGE and subsequent transfer to NC. Melanoma antigens were detected by immunoblotting with autologous dissociated serum S150. The results are illustrated in Fig. 3 . As can be seen, autologous antibody detected a 66,000-mol wt antigen in serum ultrafiltrate and spent media (Fig. 3, strips A3 and B3 ). In the cell lysate, 2-3 bands between 20,000 and 30,000 MW reacted with autologous serum (strips C2 and C3). Although other antigens were detected by autologous serum, they reacted with normal human sera as well. Normal human serum did not detect the 66,000-mol wt antigen in serum ultrafiltrate or spent media (Fig. 3 , strips Al and BJ). Nor did normal human serum react with the three 20,000-30,000-mol wt antigens found in the cell lysate (Fig. 3 , strip Cl). In one experiment, antibody S150 was exposed to 107 cells/ml of autologous melanoma Y-Mel 84:420 before immunoblotting. After absorption, S150 failed to detect the 66,000-mol wt band while still reacting with the higher molecular weight antigen (Fig. 3, strip D) .
Spent media was exposed to enzymatic digestion with pepsin (2,889 U/ml, Millipore Corp.) and trypsin (1:250, Gibco) before immunoblotting (Fig. 4) . The 66,000-mol wt antigen was lost by exposure to trypsin for 30 min (strip C). Exposure of spent media to pepsin for up to 5 h failed to ablate the antigen (strip B). Of note, exposure to trypsin resulted in the development of an additional band between 20,000 and 30,000 mol wt which appeared to correspond to the bands detected in the cell lysate. The antigen was not inactivated by heating to 100°C for 5 min.
Discussion
This study reports the successful detection and partial purification of a class II melanoma antigen detected by autologous antibody. As shown in the specificity analysis performed, the antigen is represented on a wide number of neoplastic cells but not normal cells (see Table I ). In addition, the antigen appears to be present on the cell surface and is readily shed (Fig. 3, strip C3 ). The antigen was not inactivated by heating to 1000C fOr 5 min (not shown).
in vivo (see Fig. 1 ). It is unlikely that this represents a cytoplasmic antigen as has been reported by others (30) . By using the protein A hemadsorption assay, we are able to visually confirm the presence of the antigen on the surface of melanoma cells.
The difficulty encountered by others in detecting and isolating autologous antigens has been attributed to a number of factors: loss of antigen expression in vitro, poor immunogenicity of the antigens, antigenic heterogeneity, insufficient antibody levels, and the failure to immunoprecipitate the antigens (17, 24, 31) . This report and our previous studies (20, 22, 23) would suggest an alternative explanation. We have found that the majority of patients with melanoma produce an antibody against their own tumor, however, it is masked by the presence of circulating antigen forming immune complexes. This would account for the low frequency and titer of autologous antibody in native serum and the problems encountered in antigen isolation. Our ability to significantly enhance antibody titer by acid dissociation and ultrafiltration has facilitated the isolation of autologous antigen. The autologous antibody titer of 1:262,044 found in dissociated serum S150 is over 100-fold higher than any previously reported.
The antigen isolated in these studies may be similar to the three class II melanoma antigens reported previously (20, 22 (6, 32) , the distribution ofthese antigens on a wide variety of normal and xenogeneic tissues differs from what was noted in this study. In addition, because the antigen can be isolated by PAGE, it is unlikely that this antigen is similar to the gangliosides GD2 or GM2 which cannot be isolated by PAGE and are detected through the use of chloroform/methanol extraction and thin-layer chromatography (31, (33) (34) (35) .
In addition to the 66,000-mol wt antigen detected after PAGE, other bands were noted as well (Fig. 3) . However, because these antigens were detected by normal human as well as autologous sera their significance is less clear cut. While antigens detected by allogeneic antibodies may be significant, previous studies (6, 32) have shown them to react with normal cell constituents. The fact that the 66,000-mol wt antigen was not detected by normal human sera makes it all the more relevant. Because the higher molecular weight bands are detected by normal human sera, it is unlikely that the 66,000-mol wt antigen, which was only identified by autologous sera, represents a breakdown product of those bands. In addition, reactivity of the higher molecular weight band with S150 was not removed by absorption with autologous melanoma Y-Mel 84:420.
One discrepancy in our findings relates to the differences noted between the antigens detected in the ultrafiltrate and spent media as opposed to those found in the cell lysate. Autol 
